US20060165735A1 - Stable emulsions of oils in aqueous solutions and methods for producing same - Google Patents

Stable emulsions of oils in aqueous solutions and methods for producing same Download PDF

Info

Publication number
US20060165735A1
US20060165735A1 US10/518,957 US51895705A US2006165735A1 US 20060165735 A1 US20060165735 A1 US 20060165735A1 US 51895705 A US51895705 A US 51895705A US 2006165735 A1 US2006165735 A1 US 2006165735A1
Authority
US
United States
Prior art keywords
oil
emulsion
product
oil emulsion
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/518,957
Inventor
Jesus Abril
George Stagnitti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Martek Biosciences Corp
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Priority to US10/518,957 priority Critical patent/US20060165735A1/en
Assigned to MARTEK BIOSCIENCES CORPORATION reassignment MARTEK BIOSCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ABRIL, JESUS RUBEN, STAGNITTI, GEORGE E.
Publication of US20060165735A1 publication Critical patent/US20060165735A1/en
Priority to US12/791,714 priority patent/US8529979B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01Other fatty acid esters, e.g. phosphatides
    • A23D7/011Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/017Mixtures of compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/14Derivatives of phosphoric acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Definitions

  • the present invention is directed to oil-in-water emulsions, and in particular, emulsions that help protect oils from oxidation, especially oils that are susceptible to oxidation.
  • oil and polysorbate (or lecithin) and water have been combined to produce an emulsion, but the results have been unsatisfactory.
  • Oil and xanthan gum and water mixtures are only temporarily stable, like those found in salad dressings. Emulsification of oil can also be achieved through the addition of water to the oil, combined with strong, lengthy agitation, but the resulting emulsion is very unstable.
  • LCPUFA-containing oils in aqueous mixtures, such as aqueous food, cosmetic, pharmaceutical and industrial product matrices, without having the oil and water separate into two distinct phases. It would be advantageous to find ways to stabilize an oil-in-water emulsion over a long period of time, in other words, to form an emulsion that is physically stable (e.g., the oil and the water do not phase separate) for at least 30 days. It would be advantageous if the oil is protected by the emulsion from oxidation, in particular, when the oil is susceptible to oxidation, such as a LCPUFA oil.
  • the present invention is directed toward an oil emulsion.
  • the emulsion includes an oil component, an emulsifier, an emulsion stabilizer, and water.
  • the oil component can include polyunsaturated fatty acids, such as polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
  • Exemplary oil components include linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docasapentaenoic acid, docosahexaenoic acid and mixtures thereof.
  • the oil component can be an oil from plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof.
  • plants can include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage, and mixtures thereof.
  • the genetic modifications can include the introduction or modification of polyketide synthase genes.
  • the oil component can also include an oil from a microbial source such as Thraustochytriales, dinoflagellates, and fungal sources.
  • the emulsifier is selected from the group of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, sodium lauryl sulfate and mixtures thereof
  • the emulsifier and the oil can be from the same source.
  • the stabilizer can be selected from the group of xanthan gum, alginate, gellan gum, carboxymethylcellulose, chitin and mixtures thereof.
  • the weight ratio of the oil component to the emulsifier can be between about 1: 1 and about 99: 1, and is preferably about 6: 1.
  • the ratio of water to emulsion stabilizer can be between about 1:0.1 and about 1:0.001.
  • the ratio of oil component to water can be between about 2:1 and about 1:25.
  • Oil emulsions of the present invention are highly stable and can be physically and/or chemically stable for at least about 30 days.
  • the emulsion of the present invention can be an oil-in-water emulsion. Further, the emulsion can be produced without having been heat treated. The emulsion can also have a total bacteria count of less than 20MPN/gram. In other embodiments, the oil emulsion can include an antimicrobial component, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
  • an antimicrobial component such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
  • the emulsion of the present invention can also include functionally active ingredients, such as flavors, pigments, sweeteners and anti-oxidants.
  • the emulsion can also include bioactive ingredients, such as vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
  • inventions include food products, cosmetic products, pharmaceutical products, nutriceutical products, and industrial products that include the oil emulsions of the invention.
  • Alternative embodiments of the present invention include a method for forming an emulsion.
  • the method includes combining an oil component, an emulsifier, an emulsion stabilizer and water.
  • the oil component and emusifier are combined; the emulsion stabilizer and the water are combined; and then, the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined.
  • the various components of the emulsion can be combined with high shear mixing.
  • an oil emulsion in a preferred embodiment of the present invention, includes an oil component that includes polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
  • the emulsion further includes an emulsifier, an emulsion stabilizer, water and an antimicrobial component.
  • the weight ratio of oil component to emulsifier is between about 1:1 and about 99: 1.
  • the ratio of water to emulsion stabilizer is between about 1:0.1 and about 1:0.001.
  • the ratio of oil component to water is between about 2:1 and about 1:25.
  • This oil emulsion composition is physically and chemically stable for at least about 30 days.
  • FIG. 1 is a flowsheet of an example of preparation of an emulsion of the present invention.
  • a method for forming stable emulsions, particularly including LCPUFA.
  • the method includes the step of mixing at least four ingredients: (1) oil; (2) emulsion stabilizer; (3) emulsifier; and (4) water.
  • the resulting emulsion is an oil-in-water emulsion with water as the continuous phase. It is believed that the emulsion stabilizer assists in maintaining the long-term stability of the emulsion without the need to agitate the solution continually for even distribution, preventing the oxidation of the LCPUFA oils and maintaining the integrity of the oils, thereby enhancing a longer shelf life of the product.
  • the emulsion is stable for at least 30 days, and more preferably for at least 60 days.
  • the resulting emulsions are very stable over a wide range of pH conditions and temperatures, and the LCPUFA oils are highly protected from oxidation.
  • These emulsions can exist as stand-alone products and can easily be incorporated into a wide range of products, including food, personal care and industrial products (e.g., human foods, animal feeds, pharmaceuticals, nutraceuticals, cosmetics, industrial products, etc.).
  • a particular advantage of the products of the present invention is that they can be uniformly dispersed in a wide variety of end products.
  • the oil component of emulsions of the present invention can include any oil, preferably, any vegetable or microbial oil, including for example, oils having LCPUFA.
  • Long chain PUFA oils can include any oil containing a fatty acid with at least two, and more preferably three or more double bonds, and a chain length of at least 18 carbons.
  • LCPUFA oils examples include oils containing the fatty acids linolenic acid (18:3n-3), stearidonic acid (18:4n-3) arachidonic acid (20:4n-6), eicosapentaenoic acid (20:5n-3), docosapentaenoic acid (22:5n-3 and 22:5n-6) and docosahexaenoic acid (22:6n-3).
  • oils include oils from fish oils, microbial oils (e.g.
  • Thraustochytriales such as Schizochytrium and Thraustochytrium, from dinoflagellates such as Ctypthecodinium, and from fungal sources such as Mortierella ), plants, and oilseeds, as well as genetically modified fish oils, microbial oils, plants, and oilseeds.
  • Sources of fatty acids can include oils from animal, plant and microbial sources.
  • oils can include oils from animal, plant and microbial sources.
  • the term “oil” is used broadly to include fats and oils in various forms. The oil must be capable of emulsification.
  • Preferred oils include triacylglycerol and ethyl ester forms of LCPUFA.
  • the oils will be a mixture of different substances, such as triacylglycerols, ethyl esters, free fatty acids, phospholipids, sterols, etc. Such mixtures can be purified, if desired.
  • animal sources include aquatic animals (e.g., fish, marine mammals, crustaceans, rotifers, etc.) and oils extracted from animal tissues (e.g., brain, liver, eyes, etc.).
  • plant and microbial sources include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola and borage.
  • a preferred source is aquatic algae such as algae of the order Thraustochytriales , and preferably algae of the genus Thraustochytrium and Schizochytrium. It should be noted that many experts agree that Ulkenia is not a separate genus from Thraustochytrium and Schizochytrium.
  • the genera Thraustochytrium and Schizochytrium will include Ulkenia. Information regarding such algae can be found in U.S. Pat. Nos. 5,130,242 and 5,340,594, which are incorporated herein by reference in their entirety. Another preferred source is the dinoflagellate of the genus Crypthecodinium. Information regarding Crypthecodinium can be found in U.S. Pat. Nos. 5,407,957; 5,711,983; 5,397,591; and 5,492,938, which are incorporated herein by reference in their entirety. Information regarding Mortierella can be found in U.S. Pat. Nos. 5,658,767 and 5,583,019, which are incorporated herein by reference in their entirety.
  • Plant and microbial sources can include genetically modified plants and microorganisms, and preferably include genetic modified plants and microorganisms with increased or newly introduced production of PUFAs by the introduction or modification of a polyketide synthase system (PKS system).
  • PKS system polyketide synthase system
  • Oils containing the desired fatty acids can be extracted from the various sources by any suitable means, such as by supercritical fluid extraction or by extraction with solvents such as chloroform, hexane, methylene chloride, methanol and the like.
  • the oils can be extracted using extraction techniques, such as are described in U.S. patent application Ser. No. 09/766,500 and PCT Patent Application Serial No. US01/01806, both entitled “Solventless Extraction Process” and both filed Jan. 19, 2001, both of which are incorporated herein by reference in their entirety.
  • Lecithins can be extracted by any suitable technique, and are obtainable from many of the same sources from which the oils can be obtained.
  • lecithin which is useful as an emulsifier, and oil are obtained from the same source.
  • the lecithin and oil may be extracted together, or separately extracted and remixed to form the emulsion. Additional extraction and/or purification techniques are taught in PCT Patent Application Serial No. US01/12047 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials” filed Apr. 12, 2001;
  • PCT Patent Application Serial No. US01/12849 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials Using Water-Soluble Organic Solvent and Centrifugation” filed Apr. 12, 2001;
  • the oil is typically present in an amount from about 5 wt. % to about 50 wt. %, more preferably from about I0 wt. % to about 40 wt. %, and even more preferably from about 20 wt. % to about 30 wt. %.
  • the emulsifier of emulsions of the present invention can include any emulsifier, including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
  • polysorbate esters including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
  • a polysorbate ester e.g., polyethylene sorbitan monooleate (Polysorbate 80), polyoxyethylene sorbitan monolaurate (Polysorbate 20), polyoxyethylene sorbitan tristearate (Polysorbate 65) or Polysorbate 60
  • the emulsifier can be a lecithin. Lecithins can be extracted from plant seeds, (e.g., soy lecithins), and can be extracted from eggs, milk, microbes or animal sources.
  • the emulsifier is typically present in an amount from about 1 wt. % to about 20 wt. %, more preferably from about 8 wt. % to about 15 wt. %, and even more preferably from about 2 wt % to about 6 wt. %.
  • the emulsion stabilizer of the present invention functions to further stabilize the emulsion compared to the emulsion in the absence of the stabilizer.
  • the stabilizer can also function as a thickener of the emulsion.
  • the emulsion stabilizer can be selected from xanthan gum, alginate, gellan gum, carboxymethylcellulose and chitin. In a preferred embodiment of the present invention, xanthan gum is used as the stabilizer.
  • the emulsion stabilizer is typically present in an amount from about 10 wt. % to about 2 wt. %, more preferably from about 0.2 wt % to about 0.8 wt. %, and even more preferably from about 0.3 wt. % to about 0.5 wt. %.
  • Emulsions of the present invention also include water.
  • Water is typically present in an amount from about 80 wt. % to about 90 wt. %, more preferably from about 20 wt % to about 80 wt. %, and even more preferably from about 50 wt. % to about 70 wt. %.
  • Emulsions of the present invention are highly stable in terms of both physical stability (i.e., lack of separation of components) and chemical stability (i.e., lack of oxidation of the oil component).
  • Physical stability can be measured in a variety of ways. Simple visual observation of physical separation or “creaming” is an indication of separation.
  • no observable phase separation occurs after storage at 4 C, and more preferably after storage at room temperature (i.e., about 22 C), within 30 days, more preferably within 90 days, and more preferably within 180 days.
  • Another measure of physical stability is a lack of change in the particle size of micelles formed in the emulsion. As emulsions separate, the size of micelles becomes greater. In preferred embodiments of the invention, the particle size of micelles will not increase more than about 15 %, more preferably not more than about 25 %, more preferably not more than about 30 %, more preferably not more than about 40 %, and more preferably not more than about 50 %, after storage at 4 C within 30 days, more preferably within 90 days, and more preferably within 180 days.
  • Chemical stability of an emulsion can be measured in terms of oxidation of any of the species of the oil component, including linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid.
  • Oxidation can be measured by the production of secondary products of oxidation, such as by measuring peroxide values, anisidine values, or alkenal values or by conducting a headspace analysis.
  • the value of the measure after storage at room temperature (i.e., about 22 C) for 30 days will increase less than about 20% by 60 days and/or less than about 50% by 90 days.
  • the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of pH conditions. More specifically, such parameters can be met over a pH range of about 3 to about 8, more preferably from about 3 to about 7, more preferably from about 3 to about 4.
  • the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of temperature conditions. More specifically, such parameters can be met over a temperature range of up to about room temperature (i.e., about 22 C), emulsions will be most stable at refrigeration temperature of about 4 C.
  • Emulsions of the present invention can be prepared by mixing the emulsifier with the oil in an initial step.
  • the weight ratio of oil to emulsifier is between about 1:1 and about 99:1, more preferably in a range from about 3:1 to about 50:1, more preferably in a range from about 4:1 to about 25:1, more preferably in a range from about 5:1 to about 10:1, more preferably in a ratio of about 6:1.
  • Mixing can be facilitated by heating the mixture, for example, to about 60 C for about 5 minutes, but can also be mixed at room temperature.
  • water and an emulsion stabilizer are mixed. Before this step, however, additional components that are water soluble, such as antimicrobial compounds like citric acid, sodium benzoate, and potassium sorbate, can be added to the water.
  • a preferred weight ratio of water to emulsion stabilizer is in the range of about 1:0.1 to about 1:0.001, with a more preferred range of about 1:0.05 to about 1:0.005.
  • the oil/emulsifier mixture and the water/emulsion stabilizer are then combined.
  • these two mixtures are combined to achieve an oil to water ratio of between about 2:1 to about 1:25.
  • this combination can be made at room temperature for ease of preparation and to avoid unnecessary temperature stress on the oil.
  • mild heating e.g., 35 C to 40 C
  • Mixing of the oil-based and water-based components can be done with a high shear mixer to form an emulsion.
  • the emulsion can be homogenized in a homogenizer, preferably at 3000-4000 psi.
  • the resulting product can then be packaged or used in other applications as discussed below.
  • a further aspect of the present invention is that emulsions of the invention have low microbial content even without being heat treated (i.e., pasteurized).
  • pasteurization is typically conducted at high temperatures (about 180 F) for about 15 seconds.
  • Other known heat treatments include VAT, HTST, UHT and retorting.
  • Non-pasteurized compositions of the present invention have low microbial contents.
  • emulsions of the present invention can have no detectable Pseudomonas or Salmonella.
  • the emulsions can have a total bacteria count of ⁇ 20 Most Probable Number (“MPN”)/gram; a total Coliform and E.
  • MPN Most Probable Number
  • compositions of the invention can include an antimicrobial agent in an amount of between about 0.05 and about 0.1% w/w.
  • additional functionally active ingredients e.g. flavors, pigments, sweeteners or antioxidants
  • bioactive ingredients e.g. vitamins, minerals, pre-biotic compounds, pro-biotic compounds or other nutraceutical compounds
  • additional functionally active ingredients can be incorporated in the emulsion. All such ingredients will be used following the recommendations of the manufacturer/supplier, as well as applicable governmental regulatory restrictions. These ingredients can be in either solid- powder or liquid form.
  • additional functionally active ingredients can be incorporated in the emulsion or if the emulsion will be used in a food matrix, the additional ingredients can be added to the food matrix before addition of the emulsion to the food matrix.
  • the additional functionally active ingredients When the additional functionally active ingredients are added first to the emulsion, they can be added to either the oil phase or the water phase (depending on whether they are more oil or water soluble), but are preferably added to the oil phase.
  • the ingredients can be added with moderate agitation until fully dispersed in the phase being used.
  • Some such additional ingredients, such as flavors and pigments, will complement flavors and colors in foods to which emulsions containing them are added.
  • such additives can mask marine flavors contributed by the oils or emulsification agents.
  • Flavors and pigments of all types can be included in emulsions of the invention with the exception of pigments containing iron as part of the molecule and flavors and pigments having low levels of metal contaminants, such as iron and copper.
  • an LCPUFA emulsion is incorporated into liquid food products such as beverages (e.g., fruit juices and multivitamin syrups), into high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods, into intermediate moisture foods such as health food bars and cheese, into processed meats (e.g. sausages), and as an ingredient in the preparation of baked goods (e.g., bread) or cereals.
  • beverages e.g., fruit juices and multivitamin syrups
  • high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods
  • intermediate moisture foods such as health food bars and cheese
  • processed meats e.g. sausages
  • baked goods e.g., bread
  • An advantage of the emulsion of the present invention is that it can be uniformly dispersed in a wide variety of end products.
  • Nanopure water 10 is mixed with citric acid, sodium citrate, sodium benzoate, and potassium sorbate 15 by gentle mixing 20 .
  • Xanthan gum 25 is slowly added during the mixing process 20 .
  • the resulting aqueous mixture is subjected to high shear mixing 26 in a Silverson mixer at 6,500 rpm for 3 minutes
  • the oil component 30 and the emulsifier 35 either polysorbate 80 and/or lecithin are gently mixed 40 .
  • the mixture of oil and emulsifier is then subjected to high shear mixing 45 in a Silverson mixer at 6,500 rpm for 3 minutes.
  • the oil-based mixture from the high shear mixing 45 is added to the aqueous mixture from the high shear mixing 26 .
  • the oil mixture and aqueous mixture are subjected to high shear mixing 50 at 6,500 rpm for 3 minutes.
  • the resulting composition is processed in a homogenizer 55 at about 3,000 psi.
  • the composition is then packaged in sterile containers 60 .
  • This example illustrates the preparation of an emulsion of the present invention, and its stability over time and when used in a food application.
  • DHA GOLDTM oil DHA-rich oil extracted from the marine microorganism Schizochytrium sp. was added to 25 grams of polysorbate 80 . The solution was heated to 60° C. for five minutes and mixed to dissolve the polysorbate. In a separate flask, 150 mg xanthan gum was mixed with 25 grams of water and vortexed. A new solution was made by taking 5 grams of the DHA GOLD oil/polysorbate solution and mixing with the entire 25+ grams of the water/xanthan gum solution. The new mixture was mixed and then heated at 60° C. for 1 minute to form the emulsion. The resulting mixture was stored in a refrigerator (4° C.) for 30 days. At the end of 30 days, no phase separation of the oil was observed. Odor evaluation of the emulsion indicated no formation of fishy odors—the emulsion was essentially odorless.

Abstract

Methods for making highly stable, oxidation-resistant emulsions comprising an oil, an emulsifier, an emulsion stabilizer and water are provided. The invention is particularly well suited for oils that are susceptible to oxidation, such as long chain polyunsaturated fatty acid oils. The resulting emulsion is highly stable and resistant to oxidation, and is useful in a number of products and as a stand-alone product.

Description

    FIELD OF THE INVENTION
  • The present invention is directed to oil-in-water emulsions, and in particular, emulsions that help protect oils from oxidation, especially oils that are susceptible to oxidation.
  • BACKGROUND OF THE INVENTION
  • It is desirable to form oil-in-water emulsions, and various techniques have been proposed to accomplish this task
  • In the past, oil and polysorbate (or lecithin) and water have been combined to produce an emulsion, but the results have been unsatisfactory. The oil phase separated out of the mixture after relatively short periods of time and off-odors and off-tastes that developed indicated that oxidation products of the oil had formed. Oil and xanthan gum and water mixtures are only temporarily stable, like those found in salad dressings. Emulsification of oil can also be achieved through the addition of water to the oil, combined with strong, lengthy agitation, but the resulting emulsion is very unstable.
  • Newer approaches have involved the use of proteins as emulsifiers. However, these emulsions are not stable over a wide range of pH conditions. For example, a protein that forms a stable emulsion under low pH conditions (e.g., pH 4) would denature at higher pH (e.g., pH 7), and would no longer act as an emulsifier. Another problem with protein emulsifiers is that upon heating, the protein is destabilized by its conformational change.
  • The above-described techniques have failed because of the difficulty in maintaining the emulsification and the stability of the oils. The emulsification of the aqueous and oil phases is usually temporary, and the oil/water mixture typically reverts to separate aqueous and oil phases without continued agitation. When the oil is susceptible to oxidation, as is the case with long chain polyunsaturated fatty acids (LCPUFA), stability of the product is also diminished due to the more rapid oxidation of the oils, and in particular, the LCPUFA oils. Protein-based emulsions are not stable over the wide range of pH and temperature conditions found in foods.
  • It would be advantageous to incorporate LCPUFA-containing oils in aqueous mixtures, such as aqueous food, cosmetic, pharmaceutical and industrial product matrices, without having the oil and water separate into two distinct phases. It would be advantageous to find ways to stabilize an oil-in-water emulsion over a long period of time, in other words, to form an emulsion that is physically stable (e.g., the oil and the water do not phase separate) for at least 30 days. It would be advantageous if the oil is protected by the emulsion from oxidation, in particular, when the oil is susceptible to oxidation, such as a LCPUFA oil.
  • SUMMARY OF THE INVENTION
  • The present invention is directed toward an oil emulsion. The emulsion includes an oil component, an emulsifier, an emulsion stabilizer, and water. The oil component can include polyunsaturated fatty acids, such as polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons. Exemplary oil components include linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docasapentaenoic acid, docosahexaenoic acid and mixtures thereof.
  • The oil component can be an oil from plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof. Such plants can include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage, and mixtures thereof. When such plants are genetically modified, the genetic modifications can include the introduction or modification of polyketide synthase genes. The oil component can also include an oil from a microbial source such as Thraustochytriales, dinoflagellates, and fungal sources.
  • In one embodiment, the emulsifier is selected from the group of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, sodium lauryl sulfate and mixtures thereof In one embodiment, the emulsifier and the oil can be from the same source.
  • In particular embodiments of the present invention, the stabilizer can be selected from the group of xanthan gum, alginate, gellan gum, carboxymethylcellulose, chitin and mixtures thereof.
  • The weight ratio of the oil component to the emulsifier can be between about 1: 1 and about 99: 1, and is preferably about 6: 1. The ratio of water to emulsion stabilizer can be between about 1:0.1 and about 1:0.001. The ratio of oil component to water can be between about 2:1 and about 1:25.
  • Oil emulsions of the present invention are highly stable and can be physically and/or chemically stable for at least about 30 days.
  • The emulsion of the present invention can be an oil-in-water emulsion. Further, the emulsion can be produced without having been heat treated. The emulsion can also have a total bacteria count of less than 20MPN/gram. In other embodiments, the oil emulsion can include an antimicrobial component, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
  • The emulsion of the present invention can also include functionally active ingredients, such as flavors, pigments, sweeteners and anti-oxidants. The emulsion can also include bioactive ingredients, such as vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
  • Other embodiments of the present invention include food products, cosmetic products, pharmaceutical products, nutriceutical products, and industrial products that include the oil emulsions of the invention.
  • Alternative embodiments of the present invention include a method for forming an emulsion. The method includes combining an oil component, an emulsifier, an emulsion stabilizer and water. In one embodiment, the oil component and emusifier are combined; the emulsion stabilizer and the water are combined; and then, the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined. The various components of the emulsion can be combined with high shear mixing.
  • In a preferred embodiment of the present invention, an oil emulsion is provided. The emulsion includes an oil component that includes polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons. The emulsion further includes an emulsifier, an emulsion stabilizer, water and an antimicrobial component. In this embodiment, the weight ratio of oil component to emulsifier is between about 1:1 and about 99: 1. The ratio of water to emulsion stabilizer is between about 1:0.1 and about 1:0.001. The ratio of oil component to water is between about 2:1 and about 1:25. This oil emulsion composition is physically and chemically stable for at least about 30 days.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a flowsheet of an example of preparation of an emulsion of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In accordance with one embodiment of the present invention, a method is provided for forming stable emulsions, particularly including LCPUFA. The method includes the step of mixing at least four ingredients: (1) oil; (2) emulsion stabilizer; (3) emulsifier; and (4) water. The resulting emulsion is an oil-in-water emulsion with water as the continuous phase. It is believed that the emulsion stabilizer assists in maintaining the long-term stability of the emulsion without the need to agitate the solution continually for even distribution, preventing the oxidation of the LCPUFA oils and maintaining the integrity of the oils, thereby enhancing a longer shelf life of the product.
  • Preferably, the emulsion is stable for at least 30 days, and more preferably for at least 60 days. The resulting emulsions are very stable over a wide range of pH conditions and temperatures, and the LCPUFA oils are highly protected from oxidation. These emulsions can exist as stand-alone products and can easily be incorporated into a wide range of products, including food, personal care and industrial products (e.g., human foods, animal feeds, pharmaceuticals, nutraceuticals, cosmetics, industrial products, etc.). A particular advantage of the products of the present invention is that they can be uniformly dispersed in a wide variety of end products.
  • The oil component of emulsions of the present invention can include any oil, preferably, any vegetable or microbial oil, including for example, oils having LCPUFA. Long chain PUFA oils can include any oil containing a fatty acid with at least two, and more preferably three or more double bonds, and a chain length of at least 18 carbons. Examples of LCPUFA oils include oils containing the fatty acids linolenic acid (18:3n-3), stearidonic acid (18:4n-3) arachidonic acid (20:4n-6), eicosapentaenoic acid (20:5n-3), docosapentaenoic acid (22:5n-3 and 22:5n-6) and docosahexaenoic acid (22:6n-3). Examples of these oils include oils from fish oils, microbial oils (e.g. from Thraustochytriales, such as Schizochytrium and Thraustochytrium, from dinoflagellates such as Ctypthecodinium, and from fungal sources such as Mortierella), plants, and oilseeds, as well as genetically modified fish oils, microbial oils, plants, and oilseeds.
  • Sources of fatty acids (e.g., omega-3 and omega-6 LCPUFA) can include oils from animal, plant and microbial sources. As used herein, the term “oil” is used broadly to include fats and oils in various forms. The oil must be capable of emulsification. Preferred oils include triacylglycerol and ethyl ester forms of LCPUFA. Typically, the oils will be a mixture of different substances, such as triacylglycerols, ethyl esters, free fatty acids, phospholipids, sterols, etc. Such mixtures can be purified, if desired. Examples of animal sources include aquatic animals (e.g., fish, marine mammals, crustaceans, rotifers, etc.) and oils extracted from animal tissues (e.g., brain, liver, eyes, etc.). Examples of plant and microbial sources include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola and borage. A preferred source is aquatic algae such as algae of the order Thraustochytriales, and preferably algae of the genus Thraustochytrium and Schizochytrium. It should be noted that many experts agree that Ulkenia is not a separate genus from Thraustochytrium and Schizochytrium. As used herein, the genera Thraustochytrium and Schizochytrium will include Ulkenia. Information regarding such algae can be found in U.S. Pat. Nos. 5,130,242 and 5,340,594, which are incorporated herein by reference in their entirety. Another preferred source is the dinoflagellate of the genus Crypthecodinium. Information regarding Crypthecodinium can be found in U.S. Pat. Nos. 5,407,957; 5,711,983; 5,397,591; and 5,492,938, which are incorporated herein by reference in their entirety. Information regarding Mortierella can be found in U.S. Pat. Nos. 5,658,767 and 5,583,019, which are incorporated herein by reference in their entirety.
  • Plant and microbial sources can include genetically modified plants and microorganisms, and preferably include genetic modified plants and microorganisms with increased or newly introduced production of PUFAs by the introduction or modification of a polyketide synthase system (PKS system). Information regarding genetic modifications involving PKS systems can be found in U.S. Patent No. 6,566,583, entitled “Schizochytrium PKS Genes” issued May 20, 3003; PCT Application No. U.S. Ser. No. 00/00956 entitled “Schizochytrium PKS Genes” filed Jan. 14, 2000; U.S. Pat. Application Ser. No. 10/124,807 entitled “Product and Process for Transformation of Thraustochytriales Microorganism” filed Apr. 16, 2002; PCT patent application No. PCT/US02/12040 entitled “Product and Process for Transformation of Thraustochytriales Microorganism” filed Apr. 16, 2002; U.S. patent application Ser. No. 10/124,800 entitled “PUFA Polyketide Synthase Systems and Uses Thereof” filed Apr. 16, 2002; and PCT Patent Application No. PCT/US02/12254 entitled “PUFA Polyketide Synthase Systems and Uses Thereof” filed Apr. 16, 2002; which are incorporated herein by reference in their entirety.
  • Oils containing the desired fatty acids can be extracted from the various sources by any suitable means, such as by supercritical fluid extraction or by extraction with solvents such as chloroform, hexane, methylene chloride, methanol and the like. Alternatively, the oils can be extracted using extraction techniques, such as are described in U.S. patent application Ser. No. 09/766,500 and PCT Patent Application Serial No. US01/01806, both entitled “Solventless Extraction Process” and both filed Jan. 19, 2001, both of which are incorporated herein by reference in their entirety. Lecithins can be extracted by any suitable technique, and are obtainable from many of the same sources from which the oils can be obtained. In a preferred embodiment of the present invention, lecithin, which is useful as an emulsifier, and oil are obtained from the same source. The lecithin and oil may be extracted together, or separately extracted and remixed to form the emulsion. Additional extraction and/or purification techniques are taught in PCT Patent Application Serial No. US01/12047 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials” filed Apr. 12, 2001; PCT Patent Application Serial No. US01/12849 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials Using Water-Soluble Organic Solvent and Centrifugation” filed Apr. 12, 2001; U.S. Provisional Patent Application Serial No. 60/291,484 entitled “Production and Use of a Polar Lipid-Rich Fraction Containing Stearidonic Acid and Gamma Linolenic Acid from Plant Seeds and Microbes filed May 14, 2001; U.S. Provisional Patent Application Serial No. 60/290,899 entitled “Production and Use of a Polar-Lipid Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Patty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms” filed May 14, 2001; U.S. Pat. No. 6,399,803 entitled “Process for Separating a Triglyceride Comprising a Docosahexaenoic Acid Residue from a Mixture of Triglycerides” issued Jun. 4, 2002 filed Feb. 17, 2000; and PCT Patent Application Serial No. US01/01010 entitled “Process for Making an Enriched Mixture of Polyunsaturated Fatty Acid Esters” filed Jan. 11, 2001; all of which are incorporated herein by reference in their entirety. The extracted oils and lecithins can be evaporated under reduced pressure to produce a sample of concentrated oil material.
  • In emulsions of the present invention, the oil is typically present in an amount from about 5 wt. % to about 50 wt. %, more preferably from about I0 wt. % to about 40 wt. %, and even more preferably from about 20 wt. % to about 30 wt. %.
  • The emulsifier of emulsions of the present invention can include any emulsifier, including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate. In a preferred embodiment of the present invention, a polysorbate ester (e.g., polyethylene sorbitan monooleate (Polysorbate 80), polyoxyethylene sorbitan monolaurate (Polysorbate 20), polyoxyethylene sorbitan tristearate (Polysorbate 65) or Polysorbate 60) is used as the emulsifier. In another preferred embodiment, the emulsifier can be a lecithin. Lecithins can be extracted from plant seeds, (e.g., soy lecithins), and can be extracted from eggs, milk, microbes or animal sources.
  • In emulsions of the present invention, the emulsifier is typically present in an amount from about 1 wt. % to about 20 wt. %, more preferably from about 8 wt. % to about 15 wt. %, and even more preferably from about 2 wt % to about 6 wt. %.
  • The emulsion stabilizer of the present invention functions to further stabilize the emulsion compared to the emulsion in the absence of the stabilizer. The stabilizer can also function as a thickener of the emulsion. The emulsion stabilizer can be selected from xanthan gum, alginate, gellan gum, carboxymethylcellulose and chitin. In a preferred embodiment of the present invention, xanthan gum is used as the stabilizer.
  • In emulsions of the present invention, the emulsion stabilizer is typically present in an amount from about 10 wt. % to about 2 wt. %, more preferably from about 0.2 wt % to about 0.8 wt. %, and even more preferably from about 0.3 wt. % to about 0.5 wt. %.
  • Emulsions of the present invention also include water. Water is typically present in an amount from about 80 wt. % to about 90 wt. %, more preferably from about 20 wt % to about 80 wt. %, and even more preferably from about 50 wt. % to about 70 wt. %.
  • Emulsions of the present invention are highly stable in terms of both physical stability (i.e., lack of separation of components) and chemical stability (i.e., lack of oxidation of the oil component). Physical stability can be measured in a variety of ways. Simple visual observation of physical separation or “creaming” is an indication of separation. In preferred embodiments of the invention, no observable phase separation occurs after storage at 4 C, and more preferably after storage at room temperature (i.e., about 22 C), within 30 days, more preferably within 90 days, and more preferably within 180 days.
  • Another measure of physical stability is a lack of change in the particle size of micelles formed in the emulsion. As emulsions separate, the size of micelles becomes greater. In preferred embodiments of the invention, the particle size of micelles will not increase more than about 15 %, more preferably not more than about 25 %, more preferably not more than about 30 %, more preferably not more than about 40 %, and more preferably not more than about 50 %, after storage at 4 C within 30 days, more preferably within 90 days, and more preferably within 180 days.
  • Chemical stability of an emulsion can be measured in terms of oxidation of any of the species of the oil component, including linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid. Oxidation can be measured by the production of secondary products of oxidation, such as by measuring peroxide values, anisidine values, or alkenal values or by conducting a headspace analysis. In preferred embodiments, for any one or more of these various measures of oxidation, the value of the measure after storage at room temperature (i.e., about 22 C) for 30 days will increase less than about 20% by 60 days and/or less than about 50% by 90 days.
  • Another aspect of the physical and chemical stability of the invention is that the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of pH conditions. More specifically, such parameters can be met over a pH range of about 3 to about 8, more preferably from about 3 to about 7, more preferably from about 3 to about 4.
  • Another aspect of the physical and chemical stability of the invention is that the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of temperature conditions. More specifically, such parameters can be met over a temperature range of up to about room temperature (i.e., about 22 C), emulsions will be most stable at refrigeration temperature of about 4 C.
  • Emulsions of the present invention can be prepared by mixing the emulsifier with the oil in an initial step. Preferably, the weight ratio of oil to emulsifier is between about 1:1 and about 99:1, more preferably in a range from about 3:1 to about 50:1, more preferably in a range from about 4:1 to about 25:1, more preferably in a range from about 5:1 to about 10:1, more preferably in a ratio of about 6:1. Mixing can be facilitated by heating the mixture, for example, to about 60 C for about 5 minutes, but can also be mixed at room temperature.
  • In an independent step of the process of preparing the emulsion, water and an emulsion stabilizer are mixed. Before this step, however, additional components that are water soluble, such as antimicrobial compounds like citric acid, sodium benzoate, and potassium sorbate, can be added to the water. A preferred weight ratio of water to emulsion stabilizer is in the range of about 1:0.1 to about 1:0.001, with a more preferred range of about 1:0.05 to about 1:0.005.
  • The oil/emulsifier mixture and the water/emulsion stabilizer are then combined. Preferably, these two mixtures are combined to achieve an oil to water ratio of between about 2:1 to about 1:25. Typically, this combination can be made at room temperature for ease of preparation and to avoid unnecessary temperature stress on the oil. However, mild heating (e.g., 35 C to 40 C) can be used to facilitate combining the mixtures. Mixing of the oil-based and water-based components can be done with a high shear mixer to form an emulsion. At that point, the emulsion can be homogenized in a homogenizer, preferably at 3000-4000 psi. The resulting product can then be packaged or used in other applications as discussed below.
  • A further aspect of the present invention is that emulsions of the invention have low microbial content even without being heat treated (i.e., pasteurized). For example, pasteurization is typically conducted at high temperatures (about 180 F) for about 15 seconds. Other known heat treatments include VAT, HTST, UHT and retorting. Non-pasteurized compositions of the present invention have low microbial contents. For example, emulsions of the present invention can have no detectable Pseudomonas or Salmonella. In addition, the emulsions can have a total bacteria count of <20 Most Probable Number (“MPN”)/gram; a total Coliform and E. coli count of <20 MPN/gram; a yeast and mold count of <20 MPN/gram; and/or a Staphylococcus aureus count of <10 Colony Forming Units (“CFU”)/gram. Low microbial content can be achieved by the inclusion of antimicrobial agents, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid or citric acid in the composition. Such antimicrobial agents can be included in the composition in amounts up to the maximum allowable amount in food compositions. For example, compositions of the invention can include an antimicrobial agent in an amount of between about 0.05 and about 0.1% w/w.
  • In a preferred embodiment of the present invention, additional functionally active ingredients (e.g. flavors, pigments, sweeteners or antioxidants) or bioactive ingredients (e.g. vitamins, minerals, pre-biotic compounds, pro-biotic compounds or other nutraceutical compounds) can be incorporated in the emulsion. All such ingredients will be used following the recommendations of the manufacturer/supplier, as well as applicable governmental regulatory restrictions. These ingredients can be in either solid- powder or liquid form. Such additional functionally active ingredients can be incorporated in the emulsion or if the emulsion will be used in a food matrix, the additional ingredients can be added to the food matrix before addition of the emulsion to the food matrix. When the additional functionally active ingredients are added first to the emulsion, they can be added to either the oil phase or the water phase (depending on whether they are more oil or water soluble), but are preferably added to the oil phase. The ingredients can be added with moderate agitation until fully dispersed in the phase being used. Some such additional ingredients, such as flavors and pigments, will complement flavors and colors in foods to which emulsions containing them are added. In addition, such additives can mask marine flavors contributed by the oils or emulsification agents.
  • Flavors and pigments of all types can be included in emulsions of the invention with the exception of pigments containing iron as part of the molecule and flavors and pigments having low levels of metal contaminants, such as iron and copper.
  • In a preferred embodiment of the present invention, an LCPUFA emulsion is incorporated into liquid food products such as beverages (e.g., fruit juices and multivitamin syrups), into high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods, into intermediate moisture foods such as health food bars and cheese, into processed meats (e.g. sausages), and as an ingredient in the preparation of baked goods (e.g., bread) or cereals. The emulsion can also be used both functionally and as a source of LCPUFA in cosmetic and personal care applications and in industrial applications. An advantage of the emulsion of the present invention is that it can be uniformly dispersed in a wide variety of end products.
  • With reference to FIG. 1, an example of preparation of an emulsion of the present invention is described. Nanopure water 10 is mixed with citric acid, sodium citrate, sodium benzoate, and potassium sorbate 15 by gentle mixing 20. Xanthan gum 25 is slowly added during the mixing process 20. The resulting aqueous mixture is subjected to high shear mixing 26 in a Silverson mixer at 6,500 rpm for 3 minutes Separately, the oil component 30 and the emulsifier 35, either polysorbate 80 and/or lecithin are gently mixed 40. The mixture of oil and emulsifier is then subjected to high shear mixing 45 in a Silverson mixer at 6,500 rpm for 3 minutes. The oil-based mixture from the high shear mixing 45 is added to the aqueous mixture from the high shear mixing 26. The oil mixture and aqueous mixture are subjected to high shear mixing 50 at 6,500 rpm for 3 minutes. The resulting composition is processed in a homogenizer 55 at about 3,000 psi. The composition is then packaged in sterile containers 60.
  • This application hereby incorporates by reference U.S. Provisional Application Serial No. 60/389,813, filed Jun. 18, 2002.
  • The following experimental results are provided for the purposes of illustration and are not intended to limit the scope of the invention.
  • EXAMPLES Example 1.
  • This example illustrates the preparation of an emulsion of the present invention, and its stability over time and when used in a food application.
  • A total of 75 grams of DHA-rich oil (DHA GOLD™ oil) extracted from the marine microorganism Schizochytrium sp. was added to 25 grams of polysorbate 80. The solution was heated to 60° C. for five minutes and mixed to dissolve the polysorbate. In a separate flask, 150 mg xanthan gum was mixed with 25 grams of water and vortexed. A new solution was made by taking 5 grams of the DHA GOLD oil/polysorbate solution and mixing with the entire 25+ grams of the water/xanthan gum solution. The new mixture was mixed and then heated at 60° C. for 1 minute to form the emulsion. The resulting mixture was stored in a refrigerator (4° C.) for 30 days. At the end of 30 days, no phase separation of the oil was observed. Odor evaluation of the emulsion indicated no formation of fishy odors—the emulsion was essentially odorless.
  • To test the effects of the emulsified mixture, 16.8 grams of the emulsion formed above was added to 437 grams of liquid egg substitute product and mixed. The egg product was then cooked to produce scrambled eggs. The resulting mixture provided 99.12 mg/DHA per serving (serving size=56 g liquid). No difference could be detected in taste or odor between the cooked egg substitute containing the DHA-oil emulsion and cooked egg substitute without any DHA-oil emulsion.
  • Example 2.
  • This example illustrates the composition of a lecithin based emulsion of the present invention in Table 1.
    TABLE 1
    Lecithin Based Emulsion
    Component Wt. Percent
    DHASCO-S ®*: DHA-containing oil 27.91
    Polysorbate 80 0.30
    Lecithin 4.63
    Citric Acid Buffer (0.025M) 65.66
    Xanthan Gum 0.43
    Sodium Benzoate 0.05
    Potassium Sorbate 0.05
    TOTAL 100.00

    *Registered trademark of Martek Biosciences Corporation
  • Example 3.
  • This example illustrates the composition of a polysorbate based emulsion of the present invention in Table 2.
    TABLE 2
    Polysorbate Based Emulsion
    Component Wt. Percent
    DHASCO-S ®: DHA-containing oil 27.91
    Polysorbate 80 4.92
    Citric Acid Buffer (0.025M) 66.56
    Xanthan Gum 0.43
    Sodium Benzoate 0.05
    Potassium Sorbate 0.05
    TOTAL 100.00
  • Those skilled in the art will appreciate that numerous changes and modifications may be made to the preferred embodiments of the invention and that such changes and modifications may be made without departing from the spirit of the invention. It is therefore intended that the appended claims cover all such equivalent variations as fall within the true spirit and scope of the invention.

Claims (68)

1-90. (canceled)
91. An oil emulsion, comprising:
an oil component comprising polyunsaturated fatty acids;
an emulsifier;
an emulsion stabilizer; and
water;
wherein the oil emulsion has not been heat treated.
92. The oil emulsion, as claimed in claim 91, wherein the oil component comprises polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
93. The oil emulsion, as claimed in claim 91, wherein the oil component comprises a fatty acid selected from the group consisting of linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid and mixtures thereof.
94. The oil emulsion, as claimed in claim 91, wherein the oil component comprises an oil from a source selected from the group consisting of plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof.
95. The oil emulsion, as claimed in claim 94, wherein the plants are selected from the group consisting of algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage and mixtures thereof.
96. The oil emulsion, as claimed in claim 94, wherein the genetically modified plants and genetically modified microbial oils are genetically modified by the introduction or modification of polyketide synthase genes.
97. The oil emulsion, as claimed in claim 91, wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
98. The oil emulsion, as claimed in claim 91, wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate and mixtures thereof.
99. The oil emulsion, as claimed in claim 91, wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin and mixtures thereof.
100. The oil emulsion, as claimed in claim 91, wherein the emulsifier and the oil are from the same source.
101. The oil emulsion, as claimed in claim 91, wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
102. The oil emulsion, as claimed in claim 91, further comprising an antimicrobial component.
103. The oil emulsion, as claimed in claim 102, wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
104. The oil emulsion, as claimed in claim 91, wherein the weight ratio of oil component to the emulsifier is between about 1:1 and about 99:1.
105. The oil emulsion, as claimed in claim 91, wherein the weight ratio of oil component to the emulsifier is about 6:1.
106. The oil emulsion, as claimed in claim 91, wherein the ratio of water to emulsion stabilizer is between about 1:0.1 to about 1:0.001.
107. The oil emulsion, as claimed in claim 91, wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
108. The oil emulsion, as claimed in claim 91, wherein the ratio of oil component to water is between about 2:1 to about 1:25.
109. The oil emulsion, as claimed in claim 91, wherein the oil emulsion is physically stable for at least about 30 days.
110. The oil emulsion, as claimed in claim 109, wherein the oil emulsion is physically stable for at least about 30 days at a pH range from about 3 to about 4.
111. The oil emulsion, as claimed in claim 109, wherein the oil emulsion is physically stable for at least about 30 days at a temperature range of about 4 C.
112. The oil emulsion, as claimed in claim 91, wherein the oil emulsion is chemically stable for at least about 30 days.
113. The oil emulsion, as claimed in claim 112, wherein the oil emulsion is chemically stable for at least about 30 days at a pH range from about 3 to about 4.
114. The oil emulsion, as claimed in claim 112, wherein the oil emulsion is chemically stable for at least about 30 days at a temperature range of about 4 C.
115. The oil emulsion, as claimed in claim 91, wherein the emulsion is an oil-in-water emulsion.
116. The oil emulsion, as claimed in claim 91, wherein oil emulsion has a total bacteria count of <20 MPN/gram.
117. The oil emulsion, as claimed in claim 91, wherein the emulsion further comprises functionally active ingredients.
118. The oil emulsion, as claimed in claim 117, wherein the functionally active ingredients are selected from the group consisting of flavors, pigments, sweeteners, and antioxidants.
119. The oil emulsion, as claimed in claim 91, wherein the emulsion further comprises bioactive ingredients.
120. The oil emulsion, as claimed in claim 119, wherein the bioactive ingredients are selected from the group consisting of vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
121. The oil emulsion, as claimed in claim 91, wherein the polyunsaturated fatty acids are from a marine microorganism, and wherein the oil emulsion has a pH of between about 3 to about 4.
122. A product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the product comprises an oil emulsion comprising an oil component comprising polyunsaturated fatty acids; an emulsifier; an emulsion stabilizer; and water; wherein the oil emulsion has not been heat treated.
123. The product, as claimed in claim 122, wherein the product is a food product selected from the group consisting of liquid food products and solid food products.
124. The food product, as claimed in claim 123, wherein the food product is a liquid food product selected from the group consisting of beverages, energy drinks, infant formula, liquid meals, fruit juices, multivitamin syrups, meal replacers, medicinal foods, and infant syrups.
125. The food product, as claimed in claim 123, wherein the food product is a solid food product selected from the group consisting of baby food, yogurt, cheese, cereal, pancake mixes, baked goods, food bars, processed meats, ice creams, frozen desserts, frozen yogurts, waffle mixes, and replacement egg mixes.
126. The product, as claimed in claim 122, wherein the product is a cosmetic product.
127. The product, as claimed in claim 122, wherein the product is a pharmaceutical product.
128. The product, as claimed in claim 122, wherein the product is a nutraceutical product.
129. The product, as claimed in claim 122, wherein the product is an industrial product.
130. A method of forming an emulsion, comprising combining an oil component comprising polyunsaturated fatty acids; an emulsifier; an emulsion stabilizer; and water; wherein the emulsion is not heat treated.
131. The method, as claimed in claim 130, wherein the oil component and emulsifier are combined, the emulsion stabilizer and the water are combined; and the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined.
132. The method, as claimed in claim 131, wherein the oil component/emulsifier combination is made with high shear mixing and the combination of the oil component/emulsifier combination and the emulsion stabilizer/water combination is made with high shear mixing.
133. The method, as claimed in claim 130, wherein the oil component comprises polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
134. The method, as claimed in claim 130, wherein the oil component comprises a fatty acid selected from the group consisting of linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid and mixtures thereof.
135. The method, as claimed in claim 130, wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
136. The method, as claimed in claim 130, wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
137. The method, as claimed in claim 130, wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin and mixtures thereof.
138. The method, as claimed in claim 130, wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
139. The method, as claimed in claim 130, further comprising an antimicrobial component.
140. The method, as claimed in claim 139, wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
141. The method, as claimed in claim 130, wherein the weight ratio of oil component to the emulsifier is about 6:1.
142. The method, as claimed in claim 130, wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
143. The method, as claimed in claim 130, wherein the ratio of oil component to water is between about 2:1 to about 1:25.
144. The method, as claimed in claim 130, wherein the emulsion is physically stable for at least about 30 days.
145. The method, as claimed in claim 130, wherein the emulsion is chemically stable for at least about 30 days.
146. The method, as claimed in claim 130, wherein the emulsion is an oil-in-water emulsion.
147. The method, as claimed in claim 130, wherein the emulsion has not been heat treated.
148. The method, as claimed in claim 130, wherein the emulsion has a total bacteria count of <20 MPN/gram.
149. A process for preparing a product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the process comprises the method as claimed in claim 130.
150. An oil emulsion, comprising:
a. an oil component comprising polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons; an emulsifier;
b. an emulsion stabilizer;
c. water; and
d. an antimicrobial component;
wherein the weight ratio of oil component to the emulsifier is between about 1:1 and about 99:1;
wherein the ratio of water to emulsion stabilizer is between about 1:0.1 to about 1:0.001;
wherein the ratio of oil component to water is between about 2:1 to about 1:25; and
wherein the oil emulsion is physically and chemically stable for at least about 30 days.
151. The oil emulsion, as claimed in claim 150, wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
152. The oil emulsion, as claimed in claim 150, wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithins and mixtures thereof.
153. The oil emulsion, as claimed in claim 150, wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
154. The oil emulsion, as claimed in claim 150, wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
155. The oil emulsion, as claimed in claim 150, wherein the weight ratio of oil component to the emulsifier is about 6:1.
156. The oil emulsion, as claimed in claim 150, wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
157. A product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the product comprises the oil emulsion as claimed in claim 150.
US10/518,957 2002-06-18 2003-06-18 Stable emulsions of oils in aqueous solutions and methods for producing same Abandoned US20060165735A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/518,957 US20060165735A1 (en) 2002-06-18 2003-06-18 Stable emulsions of oils in aqueous solutions and methods for producing same
US12/791,714 US8529979B2 (en) 2002-06-18 2010-06-01 Stable emulsions of oils in aqueous solutions and methods for producing same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38981302P 2002-06-18 2002-06-18
US10/518,957 US20060165735A1 (en) 2002-06-18 2003-06-18 Stable emulsions of oils in aqueous solutions and methods for producing same
PCT/US2003/019108 WO2003105606A1 (en) 2002-06-18 2003-06-18 Stable emulsions of oils in aqueous solutions and methods for producing same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/791,714 Continuation US8529979B2 (en) 2002-06-18 2010-06-01 Stable emulsions of oils in aqueous solutions and methods for producing same

Publications (1)

Publication Number Publication Date
US20060165735A1 true US20060165735A1 (en) 2006-07-27

Family

ID=29736678

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/518,957 Abandoned US20060165735A1 (en) 2002-06-18 2003-06-18 Stable emulsions of oils in aqueous solutions and methods for producing same
US12/791,714 Expired - Lifetime US8529979B2 (en) 2002-06-18 2010-06-01 Stable emulsions of oils in aqueous solutions and methods for producing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/791,714 Expired - Lifetime US8529979B2 (en) 2002-06-18 2010-06-01 Stable emulsions of oils in aqueous solutions and methods for producing same

Country Status (6)

Country Link
US (2) US20060165735A1 (en)
EP (2) EP2368445A1 (en)
JP (3) JP2005529728A (en)
AU (2) AU2003238264B2 (en)
CA (1) CA2489391A1 (en)
WO (1) WO2003105606A1 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211776A1 (en) * 2005-03-16 2006-09-21 Baker Hughes Incorporated Compositions and use of mono-and polyenoic acids for breaking VES-gelled fluids
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20080152725A1 (en) * 2002-12-10 2008-06-26 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
US20090297491A1 (en) * 2008-03-20 2009-12-03 Bromley Philip J Compositions containing non-polar compounds
US20090297665A1 (en) * 2008-03-20 2009-12-03 Bromley Philip J Compositions containing non-polar compounds
US20090317532A1 (en) * 2008-06-23 2009-12-24 Bromley Philip J Compositions containing non-polar compounds
US20110236364A1 (en) * 2010-03-23 2011-09-29 Bromley Philip J Compositions containing non-polar compounds
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
US20120093998A1 (en) * 2009-02-11 2012-04-19 Karl Manfred Voelker High concentrated pufa emulsions
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
DE102011116390A1 (en) * 2011-10-20 2013-04-25 Macinwood Engineering Gesellschaft Für Die Holzindustrie Mbh A method of providing a waxy water-based emulsion for producing a wood-containing structure
US8741373B2 (en) * 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
US9302017B2 (en) 2012-03-30 2016-04-05 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US20190014808A1 (en) * 2016-04-14 2019-01-17 Clover Corporation Limited Methods of manufacturing nutritional formulations
US10287528B2 (en) 2012-03-30 2019-05-14 Micelle Biopharma, Inc. Omega-3 fatty acid ester compositions
US20200325342A1 (en) * 2019-04-12 2020-10-15 Viavi Solutions Inc. Method for manufacturing a special effect pigment using an emulsion
US10874122B2 (en) 2012-02-10 2020-12-29 Virun, Inc. Beverage compositions containing non-polar compounds
US10894027B2 (en) 2012-03-30 2021-01-19 Micelle Biopharma, Inc. Sickle cell disease treatment utilizing omega-3 fatty acids
US20210277320A1 (en) * 2018-07-02 2021-09-09 Innospec Limited Compositions, Uses and Methods for Improving The Low Temperature Properties of a Middle Distillate Fuel
US11382980B2 (en) * 2013-10-08 2022-07-12 Taiyo Kagaku Co., Ltd. Oil/fat composition containing polyunsaturated fatty acid
US11571379B2 (en) * 2020-01-24 2023-02-07 The Procter & Gamble Company Skin care composition
WO2023146984A1 (en) * 2022-01-26 2023-08-03 Amarin Pharmaceuticals Ireland Limited Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974592B2 (en) 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
KR101175774B1 (en) 2002-11-04 2012-08-21 오션 뉴트리션 캐나다 리미티드 Microcapsules having multiple shells and method for the preparation thereof
US20050074469A1 (en) * 2003-10-03 2005-04-07 Charles Signorino Stable lipophilic emulsions for acrylic coating and method of making
NO322041B1 (en) 2004-10-22 2006-08-07 Pharmalogica As Nutritional supplement containing fish oil and milk solids as emulsifier and process for preparation.
WO2006122299A2 (en) * 2005-05-11 2006-11-16 Advanced Bionutrition Corporation Fish oil in stabilized form
EA200870001A1 (en) 2005-05-12 2009-10-30 Мартек Байосайенсиз Корпорейшн HYDROLISATE BIOMASS, ITS APPLICATION AND MANUFACTURE
NO323665B1 (en) * 2005-06-27 2007-06-18 Pharmalogica As Drink comprehensive fish oil and probiotic bacteria and preparation methods.
EP1903883A4 (en) * 2005-07-01 2010-06-23 Martek Biosciences Corp Polyunsaturated fatty acid-containing oil product and uses and production thereof
CN101252844A (en) * 2005-07-01 2008-08-27 马泰克生物科学公司 Polyunsaturated fatty acid-containing oil product and uses and production thereof
US8039030B2 (en) 2005-07-01 2011-10-18 Martek Biosciences Corporation Microwaveable popcorn and methods of making
US9968120B2 (en) 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
CA2643662A1 (en) 2006-04-07 2007-10-25 Ocean Nutrition Canada Ltd. Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
BRPI0709497A2 (en) * 2006-04-11 2011-07-19 Martek Biosciences Corp food products comprising long chain polyunsaturated fatty acids and methods for preparing them
NZ596403A (en) 2006-06-05 2013-02-22 Ocean Nutrition Canada Ltd Microcapsules with improved shells with wax in the outer shell
WO2007149592A2 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Concentrated omega-3 fatty acids and mixtures containing them
TWI526162B (en) * 2006-08-14 2016-03-21 Dsm智慧財產有限公司 Enriched beverages and methods of making the same
CA2675123C (en) 2007-01-10 2017-04-11 Ocean Nutrition Canada Limited Vegetarian microcapsules
JP2010532418A (en) * 2007-06-29 2010-10-07 マーテック バイオサイエンシーズ コーポレーション Process for producing and purifying ester of polyunsaturated fatty acid
WO2009031275A1 (en) * 2007-09-04 2009-03-12 National University Corporation Tokyo University Of Marine Science And Technology Antioxidant
WO2009073397A1 (en) 2007-11-29 2009-06-11 Monsanto Technology Llc Meat products with increased levels of beneficial fatty acids
NO20081487L (en) 2008-03-27 2009-09-28 Smartfish As Health promoting drink
GB0814105D0 (en) 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
JP5288407B2 (en) * 2008-12-22 2013-09-11 長谷川香料株式会社 O / W emulsified composition of oil-soluble substance
CA2760990A1 (en) * 2009-06-30 2011-01-06 Solae, Llc Omega-3 fatty acid enriched baked foods and bar compositions
JP2012531915A (en) * 2009-06-30 2012-12-13 ソレイ リミテッド ライアビリティ カンパニー Omega-3 fatty acid enriched beverage
FR2949059B1 (en) * 2009-08-11 2012-12-28 Raphael Colicci PROCESS FOR THE PREPARATION OF AN INTEGRAL JUICE OF OLIVE, COMPOSITION OBTAINED ACCORDING TO SAID METHOD AND ITS APPLICATION IN THE FIELD OF COSMETICS AND DIETETICS
ITBS20100017A1 (en) * 2010-02-03 2011-08-04 Francesco Palladini PROCEDURE FOR THE PRODUCTION OF A FOOD AND SUPPLEMENTARY SUPPLEMENTER SO OBTAINED
US8318233B2 (en) * 2010-03-26 2012-11-27 Corn Products Development Inc Emulsions useful in beverages
CN102958520A (en) * 2010-05-20 2013-03-06 郑忠铉 Skin preparation composition for external use with excellent antibacterial and antifungal effects
US20120135104A1 (en) * 2010-11-30 2012-05-31 Bhiku Patel Enhanced Absorption of Omega Fatty Acid Oils
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
EP3777547A1 (en) 2011-11-01 2021-02-17 DSM IP Assets B.V. Oxidatively stable polyunsaturated fatty acid containing oil
CN103416759A (en) * 2012-05-24 2013-12-04 内蒙古蒙牛乳业(集团)股份有限公司 DHA emulsion, preparation method thereof and applications thereof in UHT liquid milk
CA2930510C (en) 2013-11-13 2021-10-19 Fuji Oil Holdings Inc. Fat containing polyunsaturated fatty acid
ES2607715B1 (en) * 2015-10-01 2018-01-17 Solutex Na, Lcc PROCESS FOR THE PREPARATION AND STABILIZATION OF EMULSIONS WITH OMEGA-3 THROUGH ISOMETRIC CRYSTAL NETWORKS OF CELLULOSE DERIVATIVES
AR105674A1 (en) * 2016-08-11 2017-10-25 Consejo Nac De Investigaciones Científicas Y Técnicas (Conicet) AN EDIBLE NANOEMULSION OF CHIA'S OIL
CN114788791A (en) 2017-06-23 2022-07-26 宝洁公司 Compositions and methods for improving the appearance of skin
AU2018332574A1 (en) * 2017-09-12 2020-04-02 Purac Biochem B.V. Meat treatment
KR20210011964A (en) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 How to treat a skin condition
JP2023528616A (en) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー Method for improving skin penetration of vitamin B3 compounds
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637937A (en) * 1984-07-23 1987-01-20 Asahi Denka Kogyo Kabushiki Kaisha Process for making creamy bacteria-free foamable oil-in-water emulsion including chocolate
US5156875A (en) * 1991-06-17 1992-10-20 Doyle W. Boatwright Stabilized antimicrobial food composition
US5258194A (en) * 1990-11-02 1993-11-02 Pfizer Inc. Process for preparing a browning composition
US5302408A (en) * 1987-02-18 1994-04-12 Van Den Bergh Foods Co., Division Of Conopco Inc. Edible plastified dispersion
US5324445A (en) * 1988-08-24 1994-06-28 Allied Colloids Limited Polymeric compositions
US5550156A (en) * 1991-01-24 1996-08-27 Martek Corporation Microbial oil mixtures and uses thereof
US5658767A (en) * 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
US6034130A (en) * 1997-07-22 2000-03-07 Nestec S.A. Lipid composition for infant formula and method of preparation
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6190721B1 (en) * 1997-12-03 2001-02-20 Snow Brand Milk Products Co., Ltd. Spread
US6231915B1 (en) * 1997-08-22 2001-05-15 Lipton, Division Of Conopco, Inc. Stanol comprising compositions
US6348610B1 (en) * 1999-06-04 2002-02-19 Consejo Superior De Investigaciones Cientificas (Csic) Oil from seeds with a modified fatty acid composition
US6410078B1 (en) * 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
US6423363B1 (en) * 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
US20020182303A1 (en) * 2001-03-30 2002-12-05 Ajinomoto Co., Inc. Oil-in-water type emulsion food
US20020197382A1 (en) * 2001-05-03 2002-12-26 Unilever Bestfoods North America, Division Of Conopco, Inc. Edible oil-in-water emulsion having a reduced content of oil
US6716460B2 (en) * 2001-05-14 2004-04-06 Martek Biosciences Corporation Method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
US6737084B2 (en) * 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
US6793958B2 (en) * 2000-10-27 2004-09-21 Lipton, Division Of Conopco, Inc. Emulsified food composition
US20050129739A1 (en) * 2001-05-14 2005-06-16 Gerhard Kohn Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US7029719B1 (en) * 2000-07-10 2006-04-18 Tajimaya Foods Co., Ltd. Mayonnaise-like food and method of manufacturing the same

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6016573A (en) * 1983-07-07 1985-01-28 Lion Corp Emulsified liquid dressing
JPS60118164A (en) * 1983-11-30 1985-06-25 Sakamoto Yakuhin Kogyo Kk Acidic o/w-type emulsion composition
US4913921A (en) 1987-09-11 1990-04-03 General Mills, Inc. Food products containing fish oils stabilized with fructose
US5130242A (en) * 1988-09-07 1992-07-14 Phycotech, Inc. Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US5340594A (en) * 1988-09-07 1994-08-23 Omegatech Inc. Food product having high concentrations of omega-3 highly unsaturated fatty acids
US5080921A (en) 1990-02-05 1992-01-14 Pfizer Inc. Low calorie fat substitute
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
JP2947656B2 (en) 1991-11-26 1999-09-13 花王株式会社 Emulsified fat composition
JPH05199837A (en) * 1992-01-24 1993-08-10 Nippon Oil & Fats Co Ltd O/w-type emulsion composition
JP3231075B2 (en) * 1992-04-03 2001-11-19 株式会社コーセー Cosmetic for preventing skin aging
JP3197938B2 (en) * 1992-04-03 2001-08-13 株式会社コーセー Cosmetic for preventing skin aging
JP2787884B2 (en) * 1993-01-14 1998-08-20 雪印乳業株式会社 Oil-in-water emulsified fat composition
KR100343664B1 (en) * 1993-12-20 2002-11-27 산에이겐 에후.에후. 아이. 가부시키가이샤 Stable emulsified compositions and foods containing the same
JP3438745B2 (en) 1994-03-31 2003-08-18 日本油脂株式会社 DHA-containing multi-phase emulsion type fat composition
US5583019A (en) 1995-01-24 1996-12-10 Omegatech Inc. Method for production of arachidonic acid
JP3016704B2 (en) * 1995-02-07 2000-03-06 賢一 最上 Process for producing oil-in-water food additive containing marine animal fats and oils
JP2922458B2 (en) 1996-02-28 1999-07-26 日清製油株式会社 Seasoning for stir-fry
DE19644518A1 (en) 1996-10-25 1998-04-30 Nutricia Nv Aqueous fat emulsion for use in enteral nutrition
JPH10290929A (en) * 1997-02-21 1998-11-04 Lion Corp Production of o/w type emulsion
JP4128245B2 (en) * 1997-05-02 2008-07-30 日清オイリオグループ株式会社 Emulsification stabilizer
US6566583B1 (en) 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
CA2283422A1 (en) * 1997-06-04 1998-12-10 Calgene, Llc Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
DE19756123A1 (en) * 1997-12-17 1999-06-24 Remedia Pharmazeutische Praepa Oral compositions containing unsaturated fatty acids, e.g. fish oils
US6132793A (en) * 1998-06-12 2000-10-17 Olivia Gourmet Ltd. Method of manufacturing a butterlike composition
US6638561B1 (en) 1998-06-17 2003-10-28 Dsm N.V. Microbial arachidonic acid (ARA) for use in marine feed
WO2000050547A1 (en) 1999-02-26 2000-08-31 Monsanto Company Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides
WO2000062628A1 (en) * 1999-04-16 2000-10-26 San-Ei Gen F.F.I., Inc. Sucralose-containing composition and eatable product comprising the same
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
WO2001049282A2 (en) * 2000-01-06 2001-07-12 Martek Biosciences Corporation Therapeutic preparations of highly unsaturated fatty acids
JP2001192328A (en) * 2000-01-11 2001-07-17 Nof Corp Emulsified cosmetic
DE10013156A1 (en) * 2000-03-17 2001-09-20 Volkhard Jenning Water-containing vehicle for cosmetic or dermatological compositions, in which active agents or auxiliaries are stabilized by combination of ascorbic acid or derivative, polyphenol and buffer
SE523211C2 (en) 2000-04-26 2004-04-06 Skaanemejerier Ekonomisk Foere Lipid composition comprising a protective oil and a polyunsaturated fatty acid, emulsion containing such a composition and process for preparing the emulsion
JP4031219B2 (en) * 2000-08-08 2008-01-09 花王株式会社 Oil composition
CN100421565C (en) 2000-08-08 2008-10-01 花王株式会社 Oil/fat composition
JP3403703B2 (en) * 2000-08-09 2003-05-06 佳津良 足立 Method for producing emulsified and dispersed composition and emulsified and dispersed composition obtained by the method
GB0119583D0 (en) 2001-08-10 2001-10-03 Unilever Plc Cosmetic composition and method of treating skin
JP5118284B2 (en) * 2002-01-25 2013-01-16 花王株式会社 Oil-in-water emulsion composition

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637937A (en) * 1984-07-23 1987-01-20 Asahi Denka Kogyo Kabushiki Kaisha Process for making creamy bacteria-free foamable oil-in-water emulsion including chocolate
US5302408A (en) * 1987-02-18 1994-04-12 Van Den Bergh Foods Co., Division Of Conopco Inc. Edible plastified dispersion
US5324445A (en) * 1988-08-24 1994-06-28 Allied Colloids Limited Polymeric compositions
US5258194A (en) * 1990-11-02 1993-11-02 Pfizer Inc. Process for preparing a browning composition
US5550156A (en) * 1991-01-24 1996-08-27 Martek Corporation Microbial oil mixtures and uses thereof
US5658767A (en) * 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
US5156875A (en) * 1991-06-17 1992-10-20 Doyle W. Boatwright Stabilized antimicrobial food composition
US20020081366A1 (en) * 1995-04-28 2002-06-27 Cain Frederick William Triglycerides, rich in polyunsaturated fatty acids
US6410078B1 (en) * 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
US6034130A (en) * 1997-07-22 2000-03-07 Nestec S.A. Lipid composition for infant formula and method of preparation
US6231915B1 (en) * 1997-08-22 2001-05-15 Lipton, Division Of Conopco, Inc. Stanol comprising compositions
US6423363B1 (en) * 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
US6190721B1 (en) * 1997-12-03 2001-02-20 Snow Brand Milk Products Co., Ltd. Spread
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6348610B1 (en) * 1999-06-04 2002-02-19 Consejo Superior De Investigaciones Cientificas (Csic) Oil from seeds with a modified fatty acid composition
US6737084B2 (en) * 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
US7029719B1 (en) * 2000-07-10 2006-04-18 Tajimaya Foods Co., Ltd. Mayonnaise-like food and method of manufacturing the same
US6793958B2 (en) * 2000-10-27 2004-09-21 Lipton, Division Of Conopco, Inc. Emulsified food composition
US20020182303A1 (en) * 2001-03-30 2002-12-05 Ajinomoto Co., Inc. Oil-in-water type emulsion food
US20020197382A1 (en) * 2001-05-03 2002-12-26 Unilever Bestfoods North America, Division Of Conopco, Inc. Edible oil-in-water emulsion having a reduced content of oil
US6716460B2 (en) * 2001-05-14 2004-04-06 Martek Biosciences Corporation Method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
US20050129739A1 (en) * 2001-05-14 2005-06-16 Gerhard Kohn Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152725A1 (en) * 2002-12-10 2008-06-26 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
US10265343B2 (en) 2004-08-12 2019-04-23 Exeltis Usa, Inc. Kits and methods for nutrition supplementation
US8609629B2 (en) 2004-08-12 2013-12-17 Evertt Laboratories, Inc. Kits and methods for nutrition supplementation
US20060211776A1 (en) * 2005-03-16 2006-09-21 Baker Hughes Incorporated Compositions and use of mono-and polyenoic acids for breaking VES-gelled fluids
US7645724B2 (en) * 2005-03-16 2010-01-12 Baker Hughes Incorporated Compositions and use of mono- and polyenoic acids for breaking VES-gelled fluids
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US10220007B2 (en) 2008-03-20 2019-03-05 Virun, Inc. Compositions containing non-polar compounds
US20090297665A1 (en) * 2008-03-20 2009-12-03 Bromley Philip J Compositions containing non-polar compounds
US8765661B2 (en) 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US9788564B2 (en) 2008-03-20 2017-10-17 Virun, Inc. Compositions containing non-polar compounds
US8282977B2 (en) 2008-03-20 2012-10-09 Virun, Inc. Compositions containing non-polar compounds
US20090297491A1 (en) * 2008-03-20 2009-12-03 Bromley Philip J Compositions containing non-polar compounds
US10668029B2 (en) 2008-03-20 2020-06-02 Virun, Inc. Compositions containing non-polar compounds
US20090317532A1 (en) * 2008-06-23 2009-12-24 Bromley Philip J Compositions containing non-polar compounds
CN102131407A (en) * 2008-06-23 2011-07-20 维尔恩公司 Compositions containing nono-polar compounds
US8337931B2 (en) 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
KR101805200B1 (en) * 2009-02-11 2017-12-05 디에스엠 아이피 어셋츠 비.브이. High concentrated pufa emulsions
US20120093998A1 (en) * 2009-02-11 2012-04-19 Karl Manfred Voelker High concentrated pufa emulsions
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
US10668038B2 (en) 2009-10-16 2020-06-02 Mochida Pharmaceutical Co., Ltd. Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
US20110236364A1 (en) * 2010-03-23 2011-09-29 Bromley Philip J Compositions containing non-polar compounds
US9320295B2 (en) 2010-03-23 2016-04-26 Virun, Inc. Compositions containing non-polar compounds
US10335385B2 (en) * 2010-06-21 2019-07-02 Virun, Inc. Composition containing non-polar compounds
US20140227242A1 (en) * 2010-06-21 2014-08-14 Philip J. Bromley Compositions containing non-polar compounds
US8741373B2 (en) * 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8545896B2 (en) 2011-09-29 2013-10-01 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
DE102011116390A1 (en) * 2011-10-20 2013-04-25 Macinwood Engineering Gesellschaft Für Die Holzindustrie Mbh A method of providing a waxy water-based emulsion for producing a wood-containing structure
US10874122B2 (en) 2012-02-10 2020-12-29 Virun, Inc. Beverage compositions containing non-polar compounds
US9375490B2 (en) 2012-03-30 2016-06-28 Sancilio & Company, Inc. Stable micelles of fatty acid esters for the treatment of disease states
US10898458B2 (en) 2012-03-30 2021-01-26 Micelle Biopharma, Inc. Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
US9370585B2 (en) 2012-03-30 2016-06-21 Sancilio & Company, Inc. Stable micelles of mixed fatty acids
US9364558B2 (en) 2012-03-30 2016-06-14 Sancilio & Company, Inc. Stable micelles of fatty acid esters for the treatment of cardiovascular disease
US9364559B2 (en) 2012-03-30 2016-06-14 Sancilio & Company, Inc. Stable micelles of fatty acid esters
US10894027B2 (en) 2012-03-30 2021-01-19 Micelle Biopharma, Inc. Sickle cell disease treatment utilizing omega-3 fatty acids
US9302017B2 (en) 2012-03-30 2016-04-05 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US9302016B2 (en) 2012-03-30 2016-04-05 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US9364560B2 (en) 2012-03-30 2016-06-14 Sancilio & Company, Inc. Stable micelles of fatty acid esters for the treatment of non-alcoholic fatty liver diseases
US9364561B2 (en) 2012-03-30 2016-06-14 Sancilio & Company, Inc Stable micelles of fatty acid esters for the treatment of macular degeneration and primary sclerosing cholangitis
US9364562B2 (en) 2012-03-30 2016-06-14 Sancilio & Company, Inc. Functional foods and kits containing stable micelles of fatty acid esters
US10287528B2 (en) 2012-03-30 2019-05-14 Micelle Biopharma, Inc. Omega-3 fatty acid ester compositions
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US11382980B2 (en) * 2013-10-08 2022-07-12 Taiyo Kagaku Co., Ltd. Oil/fat composition containing polyunsaturated fatty acid
US10285971B2 (en) 2014-09-18 2019-05-14 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US20190014808A1 (en) * 2016-04-14 2019-01-17 Clover Corporation Limited Methods of manufacturing nutritional formulations
US20210277320A1 (en) * 2018-07-02 2021-09-09 Innospec Limited Compositions, Uses and Methods for Improving The Low Temperature Properties of a Middle Distillate Fuel
US20200325342A1 (en) * 2019-04-12 2020-10-15 Viavi Solutions Inc. Method for manufacturing a special effect pigment using an emulsion
US11655374B2 (en) * 2019-04-12 2023-05-23 Viavi Solutions Inc. Method for manufacturing a special effect pigment using an emulsion
US11571379B2 (en) * 2020-01-24 2023-02-07 The Procter & Gamble Company Skin care composition
WO2023146984A1 (en) * 2022-01-26 2023-08-03 Amarin Pharmaceuticals Ireland Limited Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment

Also Published As

Publication number Publication date
WO2003105606A1 (en) 2003-12-24
JP2006305569A (en) 2006-11-09
EP1531687A1 (en) 2005-05-25
AU2003238264B2 (en) 2009-05-21
AU2009203200A1 (en) 2009-08-27
AU2003238264A1 (en) 2003-12-31
EP1531687A4 (en) 2006-11-15
US20100298435A1 (en) 2010-11-25
US8529979B2 (en) 2013-09-10
CA2489391A1 (en) 2003-12-24
EP2368445A1 (en) 2011-09-28
JP4913477B2 (en) 2012-04-11
JP2005529728A (en) 2005-10-06
JP2011255373A (en) 2011-12-22

Similar Documents

Publication Publication Date Title
US8529979B2 (en) Stable emulsions of oils in aqueous solutions and methods for producing same
JP3414530B2 (en) Stable emulsified composition and food containing it
KR100343664B1 (en) Stable emulsified compositions and foods containing the same
US20090324636A1 (en) Fish oil in stabilized form
JP2005529728A5 (en)
JP2007525976A (en) Method for preserving foods and compositions comprising one or more phytosterols and / or phytostanols useful for this purpose
Magri et al. Self-assembled lipids for food applications: A review
Jacobsen Oxidative stability and shelf life of food emulsions
JPWO2013122122A1 (en) Milk beverage and method for producing the same
TW201832670A (en) Chocolate-like food containing highly unsaturated fatty acid, said food configured to suppress generation of unfavorable flavors
JPH06169735A (en) Nutritious drink composition
EP3213640A1 (en) Long-chain polyunsaturated fatty-acid-containing fat and food containing same
JP2016186002A (en) Antioxidant
Shahidi et al. Marine lipids as affected by processing and their quality preservation by natural antioxidants
JP2006124488A (en) Aqueous dispersion of highly unsaturated fatty acid-containing phospholipid
JP6891031B2 (en) Emulsified liquid seasoning
JP2009225724A (en) Composition containing arachidonic acid
JP3422338B2 (en) Powdered beverage containing highly unsaturated fatty acids
WO2020236075A1 (en) Increasing stability of lc-pufa
O'Dwyer Stabilisation of omega-3 oils in food and emulsion systems
JPH0739302A (en) Highly unsaturated fatty acid-containing fat and oil composition and highly unsaturated fatty acid-containing aqueous food
JP2022088160A (en) Oil-in-water emulsion composition
RU2239326C2 (en) Butter production process
CZ3185U1 (en) Dairy and cosmetic articles containing vegetable oils

Legal Events

Date Code Title Description
AS Assignment

Owner name: MARTEK BIOSCIENCES CORPORATION, MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ABRIL, JESUS RUBEN;STAGNITTI, GEORGE E.;REEL/FRAME:016175/0836

Effective date: 20050227

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION